Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha1-adrenoceptor (α1-adrenergic receptor) is a G-protein coupled receptor that mediates responses to norepinephrine and epinephrine. It plays a key role in regulating the sympathetic nervous system, influencing vasoconstriction, smooth muscle contraction, and neurotransmission. There are three main subtypes: α1A, α1B, and α1D. These receptors are therapeutic targets for several conditions including hypertension and benign prostatic hyperplasia.
Agonists activate the receptor, stimulating phospholipase C via Gq proteins, leading to increased IP3 and DAG levels, and a rise in intracellular calcium. Antagonists block the receptor, preventing activation and downstream signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha1-Adrenoceptor (α1-AR).